Journal of Thoracic Oncology · 2023 · 42 citations · 32 references
MedicineMolecular GeneticsOncologyCancer ImmunologyTumor ImmunologyTumor MicroenvironmentAneuploidyCancer ImmunotherapyCheckpoint Inhibitor TherapyImmune Checkpoint InhibitorsImmune CheckpointsTumor Immune MicroenvironmentChromosome 9P LossImmune Checkpoint Blockade ResistanceImmune Checkpoint Inhibitor ResponseImmune Checkpoint Inhibitor TherapyImmune Checkpoint ResistanceResistance To Checkpoint InhibitorsResistance To Immune Checkpoint Inhibition
32
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson et al. · New England Journal of Medicine · 2016 · 10.1K citations · Full text
Medicine, Oncology, Pharmacology +17
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
H. Borghaei, L. Paz-Ares, Leora Horn et al. · New England Journal of Medicine · 2015 · 9.5K citations · Full text
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Julie R. Brahmer, Karen L. Reckamp, Lucio Crinò et al. · New England Journal of Medicine · 2015 · 8.6K citations · Full text
Pharmacy, Oncology, Pharmacotherapy +15
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran, Zicheng Hu, Atul J. Butte · Genome biology · 2017 · 4.7K citations · Full text